Search Results for "Smecta "

01:14 EST 30th November 2015 | BioPortfolio

Matching Channels


Matching News

BRIEF-Ipsen reports Q3 group sales up 5.2 pct at 354.5 mln euros

* In Q3, sales primary care products reached 78.9 million euros, down 5.0 pct year-on-year, affected by sales decline of Smecta in China and of Tanakan in Russia

Ipsen: sales in the 3rd quarter and first nine months of 2015

Group sales up 5.2%1 in the third quarter Specialty care sales up 8.6%1, driven by Somatuline® growth in neuroendocrine tumors ...

Ipsen: 2015 Half-Year Results

Group sales up 7.9%1 driven by solid 12.0%1 growth of Specialty care, notably due to Somatuline® Core Operating Income up 3.5%, in view of the investmen...

Matching PubMed Articles


Search Whole site using Google


Advertisement Advertisement